Shiyang Zhai
0009-0005-6840-3177
6 papers found
Refreshing results…
Development of First-in-Class Dual Sirt2/HDAC6 Inhibitors as Molecular Tools for Dual Inhibition of Tubulin Deacetylation
Design, synthesis and biological evaluation of novel hybrids targeting mTOR and HDACs for potential treatment of hepatocellular carcinoma
Ligand- and structural-based discovery of potential small molecules that target the colchicine site of tubulin for cancer treatment
HybridMolDB: A Manually Curated Database Dedicated to Hybrid Molecules for Chemical Biology and Drug Discovery
Structure-activity relationship and synthetic methodologies of α-santonin derivatives with diverse bioactivities: A mini-review
Discovery, biological evaluation, structure–activity relationships and mechanism of action of pyrazolo[3,4-b]pyridin-6-one derivatives as a new class of anticancer agents
Missing publications? Search for publications with a matching author name.